This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Aspirin and prevention of cognitive decline in postmenopausal women

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • the use of low dose aspirin as a measure to prevent cognitive decline in postmenopausal women has been investigated in the Women's Health Study
    • cohort study within both arms of the women's health study, a randomised, double blind, placebo controlled trial
    • 6377 women aged 65 or more were given low dose aspirin (100 mg on alternate days) or placebo for a mean of 9.6 years
    • the study authors concluded that the evidence did not support the use of low dose aspirin in postmenopausal women to prevent cognitive decline

Reference:

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.